期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
肺癌耐药的新机制——肺癌的病理转化 被引量:1
1
作者 陈玥清 Waiying Yvonne Tang +1 位作者 童欣媛 季红斌 《癌症》 SCIE CAS CSCD 2020年第9期391-406,共16页
研究人员在提高肺癌疗效方面做出了很大努力,但其预后仍不令人满意。主要原因是对耐药机制缺乏全面的了解,缺少有效的临床治疗方法的研究。根据肺癌研究的最新进展,我们将耐药机制分为分子、细胞和病理3个水平,这3个层面对临床耐药性的... 研究人员在提高肺癌疗效方面做出了很大努力,但其预后仍不令人满意。主要原因是对耐药机制缺乏全面的了解,缺少有效的临床治疗方法的研究。根据肺癌研究的最新进展,我们将耐药机制分为分子、细胞和病理3个水平,这3个层面对临床耐药性的获得和演变都具有重要的意义。对耐药机制的研究已经开始改变临床治疗方法,改善了患者预后。在本综述中,我们重点讨论了在过去的几十年中被忽视了的与耐药相关的病理改变。 展开更多
关键词 肺癌 耐药性 病理转变
下载PDF
Pathological transition as the arising mechanism for drug resistance in lung cancer 被引量:9
2
作者 Yueqing Chen Waiying Yvonne Tang +1 位作者 Xinyuan Tong Hongbin Ji 《Cancer Communications》 SCIE 2019年第1期469-481,共13页
Despite the tremendous efforts for improving therapeutics of lung cancer patients,its prognosis remains disappoint-ing.This can be largely attributed to the lack of comprehensive understanding of drug resistance leadi... Despite the tremendous efforts for improving therapeutics of lung cancer patients,its prognosis remains disappoint-ing.This can be largely attributed to the lack of comprehensive understanding of drug resistance leading to insuf-ficient development of effective therapeutics in clinic.Based on the current progresses of lung cancer research,we classify drug resistance mechanisms into three different levels:molecular,cellular and pathological level.All these three levels have significantly contributed to the acquisition and evolution of drug resistance in clinic.Our under-standing on drug resistance mechanisms has begun to change the way of clinical practice and improve patient prognosis.In this review,we focus on discussing the pathological changes linking to drug resistance as this has been largely overlooked in the past decades. 展开更多
关键词 Lung cancer Drug resistance Pathological transition
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部